Skip to content

Search for:

New to Type 1 Diabetes

Living with Diabetes

Conferences & Community

News

About CWD

New to Type 1 Diabetes
Living with Diabetes
Conferences & Community
CWD Answers
News
About CWD
Donate to CWD
Search for:

Archives

Research News

advertisement

November 21, 2012

Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLA-A2 Transgenic NOD/SCID/IL2RG Null Mice. Free full text available in HTML and PDF formats.
Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Free full text available in PDF format.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. See also Nanoparticle treatment could combat type 1 diabetes.
Reduction in Carotid Intima-Media Thickness After Pancreatic Islet Transplantation in Patients With Type 1 Diabetes.
HLA-A*24 Is an Independent Predictor of 5-Year Progression to Diabetes in Autoantibody-Positive First-Degree Relatives of Type 1 Diabetic Patients.
Family history of Type 1 diabetes affects insulin secretion in patients with ‘Type 2’ diabetes.
Long-Term Changes in Adiposity and Glycemic Control Are Associated With Past Adenovirus Infection.
Recent incidence of type 1 diabetes mellitus in children 0–14 years in Newfoundland and Labrador, Canada climbs to over 45/100,000: a retrospective time trend study. Free full text available in PDF format.

November 14, 2012

Adult Pancreas Side Population Cells Expand after beta Cell Injury and Are a Source of Insulin-Secreting Cells. See also Pancreas stem cell discovery may lead to new diabetes treatments.
White Matter Microstructural Integrity in Youth With Type 1 Diabetes.
Periodic Extraction of Interstitial Fluid from the Site of Subcutaneous Insulin Infusion for the Measurement of Glucose: A Novel Single-Port Technique for the Treatment of Type 1 Diabetes Patients.
Delayed Small Intestinal Transit in Patients with Long-Standing Type 1 Diabetes Mellitus: Investigation of the Relationships with Clinical Features, Gastric Emptying, Psychological Distress, and Nutritional Parameters.

November 7, 2012

Can we vaccinate against Type 1 diabetes? Free full text available in HTML and PDF formats.
From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes. Free full text available in HTML and PDF formats.
Novel therapies in the management of type I diabetes mellitus.
Diabetes Death Rates Among Youths Aged <=19 Years � United States, 1968�2009.
High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Free full text available in HTML and PDF formats.

October 31, 2012

Real-time assessment of encapsulated neonatal porcine islets prior to clinical xenotransplantation.
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer.

October 24, 2012

Early Life Socioeconomic Indicators and Risk of Type 1 Diabetes in Children and Young Adults.
Residual beta cell function at diagnosis of Type 1 diabetes in children and adolescents varies with gender and season.
Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
The broad clinical phenotype of Type 1 diabetes at presentation.

October 18, 2012

Effect of insulin feedback on closed-loop glucose control: a crossover study.
Feasibility of a bihormonal closed-loop system to control postexercise and postprandial glucose excursions.
Robust fault detection system for insulin pump therapy using continuous glucose monitoring.
Inpatient studies of a Kalman-filter-based predictive pump shutoff algorithm.
Diabetic ketoacidosis at diagnosis: role of family history and class II HLA genotypes.

October 10, 2012

Comparative Pharmacokinetics and Insulin Action for Three Rapid-Acting Insulin Analogs Injected Subcutaneously With and Without Hyaluronidase.
Macroporous Three Dimensional PDMS Scaffolds for Extrahepatic Islet Transplantation.
New susceptibility Loci associated with kidney disease in type 1 diabetes. Free full text available in HTML and PDF formats.
Early Childhood Infections and the Risk of Islet Autoimmunity –
The Diabetes Autoimmunity Study in the Young (DAISY).
Therapeutic Effects of PPARalpha Agonists on Diabetic Retinopathy in Type 1 Diabetic Models.
Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus.

October 3, 2012

Closed-Loop Insulin Therapy Improves Glycemic Control in Children Aged <7 Years.
Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children.
Pancreatic beta Cell Dedifferentiation as a Mechanism of Diabetic beta Cell Failure.
Pancreas survival in simultaneous pancreas-kidney and pancreas-after-kidney transplantations: A five-year follow-up report.
Rising Incidence of Type 1 Diabetes in Belgrade Children Aged 0-14 in the Period From 1982 to 2005.
Use of continuous glucose monitoring as an outcome measure in clinical trials.
Evaluation of a Novel Continuous Glucose Monitoring-Based Method for Mealtime Insulin Dosing-the iBolus-in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Controlled Trial.
Sleep disturbances and low psychological well-being are associated with an increased risk of autoimmune diabetes in adults. Results from the Nord-Tr�ndelag Health Study.
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Free full text available in HTML and PDF formats.

September 26, 2012

Remogliflozin Etabonate, a Selective Inhibitor of the Sodium-Glucose Transporter 2, Improves Serum Glucose Profiles in Type 1 Diabetes.
Continuous Glucose Monitoring after Islet Transplantation in Type 1 Diabetes: An Excellent Graft Function (beta-Score Greater Than 7) Is Required to Abrogate Hyperglycemia, Whereas a Minimal Function Is Necessary to Suppress Severe Hypoglycemia (beta-Score Greater Than 3).
The microbiology of human hygiene and its impact on type 1 diabetes.
Prevention of Virus-Induced Type 1 Diabetes with Antibiotic Therapy.
The T1D Exchange Clinic Registry.
Modified release terbutaline (SKP1052) for hypoglycemia prevention: A proof-of-concept study in people with type 1 diabetes mellitus. See also Terbutaline and the prevention of nocturnal hypoglycemia in type 1 diabetes, previously reported (PDF).

September 19, 2012

Stem cells as a tool to improve outcomes of islet transplantation. Free full text available in HTML and PDF formats.
Glucagon secretion and signaling in the development of diabetes. Free full text available in HTML and PDF formats.
Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction.
Teplizumab for Treatment of Type 1 Diabetes Mellitus.

« Previous
1
…
52
53
54
55
56
…
94
Next »

advertisement

Last Updated: Monday, June 16, 2025 17:27:55 UTC

This internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

Terms of Use

About Us

Contact Us
- Contact Us
- Submit a Question

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes, EIN #46-3704802), a 501c3 not-for-profit organization, which is responsible for its contents. By using this site, you agree to our Terms of Use, Legal Notice and Privacy Policy.

Children with Diabetes.com © 1995-2025 | Comments and Feedback | All Rights Reserved.

Social

Four-Star Rating Badge - Full Color

DK Popup

This is a popup.

Submit Your Story

If you’d like your story to be considered for inclusion on our website, please fill out the form below.

Name*
First Last
Email*
Enter Email Confirm Email
Address
State / Province / Region Country

Please let us know about where you live.
Date of Birth*
Month
Day
Year
We ask for your birth date so that we can limit what is used on the website if you are under 18.
Date Diagnosed
Month
Day
Year
If you don't know the exact day, don't worry. Just choose the correct month and/or correct year and note this in your story.
Your Story*
Please tell us about yourself and your connection to diabetes.
Your Photo
Accepted file types: jpg, jpeg, png, Max. file size: 25 MB.
If you have a photo, upload it here.
Short Bio
Please include a short bio of yourself so we can consider it for inclusion with the story. This will appear underneath your photo.
Consent to Use My Story and Photo*
I agree with terms below.
By submitting my information, photo, and/or video, I give Children with Diabetes permission to use my story, imagery, photograph(s), and/or video(s), in its promotional materials and publicity efforts. I understand that the imagery may be used in, but not limited to, a publication, print ad, direct-mail piece, electronic media, or other form or promotion; and that my name and additional information collected by the organization may be used in conjunction with the image(s). I release Children with Diabetes from liability for any violation of any personal or proprietary right I may have in connection with such use.

Contact Us

Help Us Understand You Better.

Please answer a few questions to help us understand how best to serve you. You are not required to answer, but we hope you will. This information will be collated and may be published on our website periodically, or may be used for publication, but we will use composite data only. We do not maintain any individual data from these items. If you ask another question at a later time, please fill this out each time.

This form is just for questions related to diabetes care. If you have questions about anything else related to Children with Diabetes, please use our Contact Us form.
This question is on behalf of:
The question applies to this age group:
This question relates to:
We've had diabetes for:
We use this treatment for diabetes:
We have the following insurance:
We receive diabetes care from:
I'm asking this question because:
Type in Your Question Here.
What is your email address?
If you would like to have the answer emailed to you, please include your email address.
Where do you live?
Please tell us where you live (city, state, and country). This information can help us answer your question.
What is your question?*
To preserve confidentiality, we strongly recommend that you do not include in your question any information that identifies you, your child, or any other individual. Please note: questions that are published may be edited for space and clarity.
Comments
This field is for validation purposes and should be left unchanged.

First Name*
Last Name*
Email*
What is your connection to type 1 diabetes?*
- I have type 1 diabetes
- I have a child with type 1 diabetes
- I have type 1 and have a child with type 1
- I am a health care professional
- Other
Phone
This field is for validation purposes and should be left unchanged.